These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36933173)

  • 21. Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes.
    Singkham N; Wongsalap Y; Poolpun D; Phetnoo S; Somkhon C
    Ann Geriatr Med Res; 2021 Dec; 25(4):260-268. PubMed ID: 34958732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of the COVID-19 Pandemic on the Military Health System's Care of Military Sexual Assault.
    Lorei N; Banaag A; Perez Koehlmoos T
    Mil Med; 2024 Jul; 189(7-8):e1784-e1789. PubMed ID: 38035759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
    Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
    Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purchased Behavioral Health Care Received by Military Health System Beneficiaries in Civilian Medical Facilities, 2000-2014.
    Wooten NR; Brittingham JA; Pitner RO; Tavakoli AS; Jeffery DD; Haddock KS
    Mil Med; 2018 Jul; 183(7-8):e278-e290. PubMed ID: 29420772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
    Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
    Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of congestive heart failure--current status of use of digitoxin.
    Belz GG; Breithaupt-Grögler K; Osowski U
    Eur J Clin Invest; 2001; 31 Suppl 2():10-7. PubMed ID: 11525233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
    Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
    Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of vestibular disorders among military health system (MHS) beneficiaries, fiscal years 2018-2019.
    Sayegh MA; Banaag A; Korona-Bailey J; Madsen C; Frank A; Koehlmoos TP
    PLoS One; 2023; 18(10):e0286798. PubMed ID: 37856452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
    Chang KY; Giorgio K; Schmitz K; Walker RF; Prins KW; Pritzker MR; Archer SL; Lutsey PL; Thenappan T
    J Am Heart Assoc; 2023 Mar; 12(6):e027559. PubMed ID: 36892094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.